After carefully reading this entire thread again, it is fascinating to see the obvious change in tune of the dedicated Neurenites on here who picked up the nuances of Jon's language to see partnering as a distinct possibility.
Then, as usual, Hottod's great post shows how it can be done and suddenly it becomes real.
Partnering instead of a simple takeover would confirm one thing we have known all along - NNZ 2591 has so many possible applications it could be transformational in the neurology space and is not worth giving up completely to someone else.
I dare you to tell me you are not excited.
Ann: 2023 Results webinar, page-59
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.73 |
Change
-0.280(1.33%) |
Mkt cap ! $2.647B | |||
| Open | High | Low | Value | Volume |
| $20.87 | $21.19 | $20.70 | $6.213M | 297.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5414 | $20.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.79 | 335 | 1 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.73 |
Change
-0.280 ( 1.22 %) |
||||
| Open | High | Low | Volume | ||
| $20.99 | $21.19 | $20.69 | 94423 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| NEU (ASX) Chart |